Table 1.
Beijing (China) | Ithaca, NY (USA) | Netherlands | Tasmania | Zimbabwe | Total | |
---|---|---|---|---|---|---|
I | 1 (1) | 19 (14) | 1 (0) | 4 (1) | 1 (1) | 26 (17) |
II | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (1) | 1 (1) |
III | 3 (2) | 0 (0) | 15 (12) | 15 (15) | 16 (14) | 49 (41) |
IV | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
V | 0 (0) | 0 (0) | 2 (0) | 0 (0) | 0 (0) | 2 (0) |
VI | 0 (0) | 0 (0) | 1 (0) | 0 (0) | 0 (0) | 1 (0) |
VIII | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
VIII | 12 (6) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 12 (6) |
Total | 16 (9) | 19 (14) | 19 (12) | 19 (14) | 18 (16) | 91 (65) |
For each population, the number of sampled mtDNA haplotypes within each major clade is listed, followed by the number of lines carrying a Wolbachia infection in parentheses. Haplotypes correspond with those given in Fig 2. Clades I-VI are defined by Richardson et al. (2012); Clade VII is defined in Ilinsky (2013); clade VIII is described in this paper.